FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2014839785> ?p ?o ?g. }

• W2014839785 endingPage "571" @default.
• W2014839785 startingPage "562" @default.
• W2014839785 abstract "HomeCirculation ResearchVol. 42, No. 4The effect of agents interfering with soft tissue calcification and cell proliferation on calcific fibrous-fatty plaques in rabbits. Free AccessAbstractPDF/EPUBAboutView PDFSections ToolsAdd to favoritesDownload citationsTrack citationsPermissions ShareShare onFacebookTwitterLinked InMendeleyReddit Jump toFree AccessAbstractPDF/EPUBThe effect of agents interfering with soft tissue calcification and cell proliferation on calcific fibrous-fatty plaques in rabbits. D M Kramsch and C T Chan D M KramschD M Kramsch Search for more papers by this author and C T ChanC T Chan Search for more papers by this author Originally published1 Apr 1978https://doi.org/10.1161/01.RES.42.4.562Circulation Research. 1978;42:562–571 Previous Back to top Next FiguresReferencesRelatedDetailsCited By Afshar M, Yazdan-Ashoori S, Engert J and Thanassoulis G (2021) Drugs for Prevention and Treatment of Aortic Stenosis: How Close Are We?, Canadian Journal of Cardiology, 10.1016/j.cjca.2021.02.017, 37:7, (1016-1026), Online publication date: 1-Jul-2021. Ruderman I, Holt S, Hewitson T, Smith E and Toussaint N (2018) Current and potential therapeutic strategies for the management of vascular calcification in patients with chronic kidney disease including those on dialysis, Seminars in Dialysis, 10.1111/sdi.12710, 31:5, (487-499), Online publication date: 1-Sep-2018. Pawade T, Newby D and Dweck M (2015) Calcification in Aortic Stenosis, Journal of the American College of Cardiology, 10.1016/j.jacc.2015.05.066, 66:5, (561-577), Online publication date: 1-Aug-2015. Chen C, Chang H, Chou H, Lee M, Chen Y, Huang Y, Chen T, Chang H and Shih C (2013) Alendronate and risk of lower limb ischemic vascular events: a population-based cohort study, Osteoporosis International, 10.1007/s00198-013-2478-3, 25:2, (673-680), Online publication date: 1-Feb-2014. Synetos A, Toutouzas K, Benetos G, Drakopoulou M, Trantalis G, Kotronias R, Agrogiannis G, Tsiamis E, Deftereos S, Davlouros P, Patsouris E and Stefanadis C (2014) Catheter based inhibition of arterial calcification by bisphosphonates in an experimental atherosclerotic rabbit animal model, International Journal of Cardiology, 10.1016/j.ijcard.2014.07.008, 176:1, (177-181), Online publication date: 1-Sep-2014. Aminova R, Galiullina L, Silkin N, Ulmetov A, Klochkov V and Aganov A (2013) Investigation of complex formation between hydroxyapatite and fragments of collagen by NMR spectroscopy and quantum-chemical modeling, Journal of Molecular Structure, 10.1016/j.molstruc.2013.06.008, 1049, (13-21), Online publication date: 1-Oct-2013. Santos L, Cavalcanti T and Bandeira F (2012) Vascular Effects of Bisphosphonates–-A Systematic Review, Clinical Medicine Insights: Endocrinology and Diabetes, 10.4137/CMED.S10007, 5, (CMED.S10007), Online publication date: 1-Jan-2012. Aksoy O, Cam A, Goel S, Houghtaling P, Williams S, Ruiz-Rodriguez E, Menon V, Kapadia S, Tuzcu E, Blackstone E and Griffin B (2012) Do Bisphosphonates Slow the Progression of Aortic Stenosis?, Journal of the American College of Cardiology, 10.1016/j.jacc.2012.01.024, 59:16, (1452-1459), Online publication date: 1-Apr-2012. Mori H, Okada Y, Yamaoka K, Saito K and Tanaka Y (2011) Marked improvement of calcinosis in adult dermatomyositis with etidronate therapy, Journal of Bone and Mineral Metabolism, 10.1007/s00774-011-0289-1, 30:1, (114-118), Online publication date: 1-Jan-2012. Liu H, Zhang C and Huang K (2011) Lanthanum chloride suppresses oxysterol-induced ECV-304 cell apoptosis via inhibition of intracellular Ca2+ concentration elevation, oxidative stress, and activation of ERK and NF-κB signaling pathways, JBIC Journal of Biological Inorganic Chemistry, 10.1007/s00775-011-0766-y, 16:5, (671-681), Online publication date: 1-Jun-2011. Sharma S, Boujraf S, Bornstedt A, Hombach V, Ignatius A, Oberhuber A and Rasche V (2010) Quantification of Calcifications in Endarterectomy Samples by Means of High-Resolution Ultra-Short Echo Time Imaging, Investigative Radiology, 10.1097/RLI.0b013e3181c8cefa, 45:3, (109-113), Online publication date: 1-Mar-2010. Konstantino Y, Nguyen T, Wolk R, Aiello R, Terra S and Fryburg D (2009) Potential implications of matrix metalloproteinase-9 in assessment and treatment of coronary artery disease, Biomarkers, 10.1080/13547500902765140, 14:2, (118-129), Online publication date: 1-Mar-2009. Gutta R and Louis P (2007) Bisphosphonates and osteonecrosis of the jaws: Science and rationale, Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology, and Endodontology, 10.1016/j.tripleo.2006.12.004, 104:2, (186-193), Online publication date: 1-Aug-2007. Delibasi T, Emral R, Erdogan M and Kamel N (2007) Effects of alendronate sodium therapy on carotid intima media thickness in postmenopausal women with osteoporosis, Advances in Therapy, 10.1007/BF02849900, 24:2, (319-325), Online publication date: 1-Mar-2007. Tamura K, Suzuki Y, Matsushita M, Fujii H, Miyaura C, Aizawa S and Kogo H (2007) Prevention of aortic calcification by etidronate in the renal failure rat model, European Journal of Pharmacology, 10.1016/j.ejphar.2006.12.006, 558:1-3, (159-166), Online publication date: 1-Mar-2007. Kishikawa H, Okada Y, Kawahara T, Saito K and Tanaka Y (2007) A case of blue rubber bleb nevus syndrome treated by etidronate, Journal of Bone and Mineral Metabolism, 10.1007/s00774-006-0740-x, 25:2, (138-141), Online publication date: 26-Feb-2007. Tang F, Wu X, Wang T, Wang P, Li R, Zhang H, Gao J, Chen S, Bao L, Huang H and Liu P (2007) Tanshinone II A attenuates atherosclerotic calcification in rat model by inhibition of oxidative stress, Vascular Pharmacology, 10.1016/j.vph.2007.01.001, 46:6, (427-438), Online publication date: 1-Jun-2007. Wijdicks C and Williams J (2007) Spinal arachnoid calcifications, Clinical Anatomy, 10.1002/ca.20455, 20:5, (521-523), Online publication date: 1-Jul-2007. Tang F, Chen S, Wu X, Wang T, Chen J, Li J, Bao L, Huang H and Liu P (2006) Hypercholesterolemia Accelerates Vascular Calcification Induced by Excessive Vitamin D via Oxidative Stress, Calcified Tissue International, 10.1007/s00223-006-0004-8, 79:5, (326-339), Online publication date: 1-Nov-2006. Qunibi W (2005) Dyslipidemia and progression of cardiovascular calcification (CVC) in patients with end-stage renal disease (ESRD), Kidney International, 10.1111/j.1523-1755.2005.09507.x, 67, (S43-S50), Online publication date: 1-Jun-2005. Bevilacqua M, Dominguez L, Rosini S and Barbagallo M (2016) Bisphosphonates and atherosclerosis: why?, Lupus, 10.1191/0961203305lu2219oa, 14:9, (773-779), Online publication date: 1-Sep-2005. Nosaka T, Tanaka H, Omi N, Sato M and Matsuda M (2004) Do Exercise-induced Changes in Distensibility and Elastic Components of Rat Aorta Last for Long after the Cessation of Training?, International Journal of Sport and Health Science, 10.5432/ijshs.2.76, 2, (76-83), . Abedin M, Tintut Y and Demer L (2004) Vascular Calcification, Arteriosclerosis, Thrombosis, and Vascular Biology, 24:7, (1161-1170), Online publication date: 1-Jul-2004. Strobach D and Lorenz R (2003) The bisphosphonate ibandronate stimulates reverse cholesterol transport out of monocytoid cells by enhanced ABCA1 transcription, Biochemical and Biophysical Research Communications, 10.1016/S0006-291X(03)01127-6, 307:1, (23-30), Online publication date: 1-Jul-2003. Nishizawa Y and Koyama H (2002) Atherosclerosis Calcium in Internal Medicine, 10.1007/978-1-4471-0667-8_24, (447-460), . Proudfoot D, Davies J, Skepper J, Weissberg P and Shanahan C (2002) Acetylated Low-Density Lipoprotein Stimulates Human Vascular Smooth Muscle Cell Calcification by Promoting Osteoblastic Differentiation and Inhibiting Phagocytosis, Circulation, 10.1161/01.CIR.0000041429.83465.41, 106:24, (3044-3050), Online publication date: 10-Dec-2002. Ylitalo R, Syvälä H, Tuohimaa P and Ylitalo P (2002) Suppression of Immunoreactive Macrophages in Atheromatous Lesions of Rabbits by Clodronate, Pharmacology & Toxicology, 10.1034/j.1600-0773.2002.900305.x, 90:3, (139-143), Online publication date: 1-Mar-2002. Shafi S, Stepanova I, Fitzsimmons C, Bowyer D and Born G (2002) Long-Term Low-Dose Treatment With Reserpine of Cholesterol-Fed Rabbits Reduces Cholesterol in Plasma, Non-High Density Lipoproteins and Arterial Walls, Journal of Cardiovascular Pharmacology, 10.1097/00005344-200207000-00009, 40:1, (67-79), Online publication date: 1-Jul-2002. SU J, FUKUDA N, KISHIOKA H, HU W and KANMATSUSE K (2002) ETIDRONATE INFLUENCES GROWTH AND PHENOTYPE OF RAT VASCULAR SMOOTH MUSCLE CELLS, Pharmacological Research, 10.1016/S1043-6618(02)00041-5, 46:1, (7-13), Online publication date: 1-Jul-2002. He M, Ranz D and Rambeck W (2001) Study on the performance enhancing effect of rare earth elements in growing and fattening pigs, Journal of Animal Physiology and Animal Nutrition, 10.1046/j.1439-0396.2001.00327.x, 85:7-8, (263-270), Online publication date: 1-Aug-2001. Demir E, Bereket A, Özkan B and Topçu M Effect of Alendronate Treatment on the Clinical Picture and Bone Turnover Markers in Chronic Idiopathic Hyperphosphatasia, Journal of Pediatric Endocrinology and Metabolism, 10.1515/JPEM.2000.13.2.217, 13:2 Koshiyama H, Nakamura Y, Tanaka S and Minamikawa J (2000) Decrease in Carotid Intima-Media Thickness after 1-Year Therapy with Etidronate for Osteopenia Associated with Type 2 Diabetes1, The Journal of Clinical Endocrinology & Metabolism, 10.1210/jcem.85.8.6748, 85:8, (2793-2796), Online publication date: 1-Aug-2000. Ylitalo R (2000) Bisphosphonates and atherosclerosis, General Pharmacology: The Vascular System, 10.1016/S0306-3623(01)00121-5, 35:6, (287-296), Online publication date: 1-Dec-2000. Guo W, Morrisett J, DeBakey M, Lawrie G and Hamilton J (2000) Quantification In Situ of Crystalline Cholesterol and Calcium Phosphate Hydroxyapatite in Human Atherosclerotic Plaques by Solid-State Magic Angle Spinning NMR, Arteriosclerosis, Thrombosis, and Vascular Biology, 10.1161/01.ATV.20.6.1630, 20:6, (1630-1636), Online publication date: 1-Jun-2000. Luurila S, Kautiainen S, Ylitalo P and Ylitalo R (2017) Pharmacokinetics of Bisphosphonates in Rabbits, Pharmacology & Toxicology, 10.1111/j.1600-0773.1999.tb02106.x, 84:1, (24-28), Online publication date: 1-Jan-1999. Ylitalo R, Jaakkola O, Lehtolainen P and Ylä-Herttuala S (1999) Metabolism of modified LDL and foam cell formation in murine macrophage-like raw 264 cells, Life Sciences, 10.1016/S0024-3205(99)00140-X, 64:21, (1955-1965), Online publication date: 1-Apr-1999. Fleisch H (1998) Bisphosphonates: Mechanisms of Action, Endocrine Reviews, 10.1210/edrv.19.1.0325, 19:1, (80-100), Online publication date: 1-Feb-1998. Sinzinger H, Wasinger T, Böck P, O'Grady J and Peskar B (1998) Alteration of rat cerebral microvascular eicosanoid formation by isradipine, a calcium channel blocker, Prostaglandins, Leukotrienes and Essential Fatty Acids, 10.1016/S0952-3278(98)90123-5, 58:1, (1-7), Online publication date: 1-Jan-1998. Ylitalo R, Monkkonen J and Ylä-Herttuala S (1997) EFFECTS OF LIPOSOME-ENCAPSULATED BISPHOSPHONATES ON ACETYLATED LDL METABOLISM, LIPID ACCUMULATION AND VIABILITY OF PHAGOCYTING CELLS, Life Sciences, 10.1016/S0024-3205(97)01134-X, 62:5, (413-422), Online publication date: 1-Dec-1997. Del Rio M, Ruiz E and Tejerina T (1997) Action of elgodipine on atherosclerosis development, cell growth, and oncogene expression in vascular smooth muscle cells, General Pharmacology: The Vascular System, 10.1016/S0306-3623(96)00067-5, 28:3, (463-468), Online publication date: 1-Mar-1997. Ylitalo R, Monkkonen J, Urtti A and Ylitalo P (1996) Accumulation of bisphosphonates in the aorta and some other tissues of healthy and atherosclerotic rabbits, Journal of Laboratory and Clinical Medicine, 10.1016/S0022-2143(96)90079-7, 127:2, (200-206), Online publication date: 1-Feb-1996. Fleisch H (1994) Bisphosphonates: Mechanisms of Action and Clinical Use in Hypercalcemia of Malignancy and Tumor-Induced Bone Destruction Metastatic Bone Disease, 10.1007/978-3-642-78596-2_12, (144-176), . Jayo J, Schwenke D and Clarkson T (1994) Atherosclerosis Research The Biology of the Laboratory Rabbit, 10.1016/B978-0-12-469235-0.50023-3, (367-380), . Fleisch H (1993) Bisphosphonates: Mechanisms of Action and Clinical Use Physiology and Pharmacology of Bone, 10.1007/978-3-642-77991-6_11, (377-418), . Swindella A, Krupp M, Twomey T, Reynolds J and Chichester C (1993) Effects of doxazosin on atherosclerosis in cholesterol-fed rabbits, Atherosclerosis, 10.1016/0021-9150(93)90022-M, 99:2, (195-206), Online publication date: 1-Mar-1993. Golomb G, Schlossman A, Eitan Y, Saadeh H, Van Gelder J and Breuer E (1992) In Vitro and In Vivo Anticalcification Effects of Novel Bishydroxyiminophosphonates, Journal of Pharmaceutical Sciences, 10.1002/jps.2600811009, 81:10, (1004-1007), Online publication date: 1-Oct-1992. Jost S, Rafflenbeul W, Deckers J, Wiese B, Hecker H, Nikutta P, Lippolt P and Lichtlen P (1992) Concept of an antiatherosclerotic efficacy of calcium entry blockers, European Journal of Epidemiology, 10.1007/BF00145361, 8:S1, (107-119), Online publication date: 1-May-1992. Sinzinger H, Virgolini I, Rauscha F, Fitscha P and O'Grady J (1992) Isradipine improves platelet function in hypertensives, European Journal of Clinical Pharmacology, 10.1007/BF00314918, 42:1, (43-46), Online publication date: 1-Jan-1992. Detrano R and Molloi S (1992) Radiographically detectable calcium and atherosclerosis: the connection and its exploitation, The International Journal of Cardiac Imaging, 10.1007/BF01146839, 8:3, (209-215), Online publication date: 1-Sep-1992. Gott J, Pan-Chih , Dorsey L, Jay J, Jett G, Schoen F, Girardot J and Guyton R (1992) Calcification of porcine valves: A successful new method of antimineralization, The Annals of Thoracic Surgery, 10.1016/0003-4975(92)91321-Y, 53:2, (207-216), Online publication date: 1-Feb-1992. Moon J, Bandy B and Davison A (1992) Hypothesis: etiology of atherosclerosis and osteoporosis: are imbalances in the calciferol endocrine system implicated?, Journal of the American College of Nutrition, 10.1080/07315724.1992.10718263, 11:5, (567-583), Online publication date: 1-Oct-1992. Mallette L, Hollis B, Dunn K, Stinson M, Dunn J, Wittels E and Gotto A (1991) Ten Weeks of Intermittent Hypocalcemic Stimulation Does Not Produce Functional Parathyroid Hyperplasia, The American Journal of the Medical Sciences, 10.1097/00000441-199109000-00002, 302:3, (138-141), Online publication date: 1-Sep-1991. Sperti G and Colucci W (1991) Calcium influx modulates DNA synthesis and proliferation in A7r5 vascular smooth muscle cells, European Journal of Pharmacology: Molecular Pharmacology, 10.1016/0922-4106(91)90110-4, 206:4, (279-284), Online publication date: 1-Apr-1991. Parmley W (1990) Vascular protection from atherosclerosis: Potential of calcium antagonists, The American Journal of Cardiology, 10.1016/0002-9149(90)91259-9, 66:21, (16-22), Online publication date: 1-Dec-1990. Petty M, Kintz J and DiFrancesco G (1990) The effects of taurine on atherosclerosis development in cholesterol-fed rabbits, European Journal of Pharmacology, 10.1016/0014-2999(90)90599-2, 180:1, (119-127), Online publication date: 1-May-1990. Knorr A and Kazda S (1990) Influence of nifedipine on experimental arteriosclerosis, Cardiovascular Drugs and Therapy, 10.1007/BF02018312, 4:S5, (1027-1031), Online publication date: 1-Sep-1990. Gasser R (2016) Calcium Antagonists: Pharmacologic Agents in Search of New Clinical Indications, Angiology, 10.1177/000331979004100106, 41:1, (36-43), Online publication date: 1-Jan-1990. Evans C (1990) Past, Present, and Possible Future Clinical Applications of the Lanthanides Biochemistry of the Lanthanides, 10.1007/978-1-4684-8748-0_9, (391-425), . Silberstein E, Clark R and Delong S (1989) Clinical and radiographic correlates of femoral artery visualization on bone scan, International Journal of Radiation Applications and Instrumentation. Part B. Nuclear Medicine and Biology, 10.1016/0883-2897(89)90143-8, 16:7, (709-713), Online publication date: 1-Jan-1989. Fleisch H (1989) Bisphosphonates: A New Class of Drugs in Diseases of Bone and Calcium Metabolism Bisphosphonates and Tumor Osteolysis, 10.1007/978-3-642-83668-8_1, (1-28), . Clubb F, Schmitz J, Butler M, Buja L, Willerson J and Campbell W (1989) Effect of dietary omega-3 fatty acid on serum lipids, platelet function, and atherosclerosis in Watanabe heritable hyperlipidemic rabbits., Arteriosclerosis: An Official Journal of the American Heart Association, Inc., 9:4, (529-537), Online publication date: 1-Jul-1989. Weinstein D and Heider J (1989) Antiatherogenic properties of calcium antagonists, The American Journal of Medicine, 10.1016/0002-9343(89)90186-1, 86:4, (27-32), Online publication date: 1-Apr-1989. Fleisch H (1988) Bisphosphonates: A New Class of Drugs in Diseases of Bone and Calcium Metabolism Calcium in Drug Actions, 10.1007/978-3-642-71806-9_21, (441-466), . Betz E (1988) Experimentelle Grundlagen zur Sekundärprophylaxe arteriosklerotischer Erkrankungen hirnversorgender Gefäße mit Calcium-Antagonisten Calcium-Antagonisten in der Neurologie, 10.1007/978-3-642-73300-0_5, (58-75), . Smith R, Wolf P, Regan J and Jolly S (1988) References The Emergence of Drugs which Block Calcium Entry, 10.1007/978-3-642-73228-7_9, (115-152), . HENRY P (1988) Calcium Antagonists as Antiatherogenic Agents, Annals of the New York Academy of Sciences, 10.1111/j.1749-6632.1988.tb33382.x, 522:1 Calcium Antag, (411-419), Online publication date: 1-Mar-1988. Schmitz G, Robenek H, Beuck M, Krause R, Schurek A and Niemann R (1988) Ca++ antagonists and ACAT inhibitors promote cholesterol efflux from macrophages by different mechanisms. I. Characterization of cellular lipid metabolism., Arteriosclerosis: An Official Journal of the American Heart Association, Inc., 8:1, (46-56), Online publication date: 1-Jan-1988.Strickberger S, Russek L and Phair R (1988) Evidence for increased aortic plasma membrane calcium transport caused by experimental atherosclerosis in rabbits., Circulation Research, 62:1, (75-80), Online publication date: 1-Jan-1988. Sievers R, Rashid T, Garrett J, Blumlein S and Parmley W (1987) Verapamil and diet halt progression of atherosclerosis in cholesterol fed rabbits, Cardiovascular Drugs and Therapy, 10.1007/BF02125835, 1:1, (65-69), Online publication date: 1-Jan-1987. Parmley W (1987) Calcium channel blockers and atherogenesis, The American Journal of Medicine, 10.1016/0002-9343(87)90204-X, 82:3, (3-8), Online publication date: 1-Mar-1987. Weinstein D and Heider J (1987) Antiatherogenic properties of calcium antagonists, The American Journal of Cardiology, 10.1016/0002-9149(87)90097-X, 59:3, (B163-B172), Online publication date: 1-Jan-1987. A. C, Granata A, Fumagalli R and Paoletti R (1986) Calcium antagonists and low density lipoproteins metabolism by human fibroblasts and by human hepatoma cell line HEP G2, Pharmacological Research Communications, 10.1016/0031-6989(86)90155-4, 18:1, (1-16), Online publication date: 1-Jan-1986. Kamphues J, Carstensen P, Schroeder D, Meyer H, Schoon H and Rosenbruch M (1986) Effekte einer steigenden Calcium- und Vitamin D-Zufuhr auf den Calciumstoffwechsel von Kaninchen, Journal of Animal Physiology and Animal Nutrition, 10.1111/j.1439-0396.1986.tb00564.x, 56:1-5, (191-208), Online publication date: 12-Sep-1986. Sugano M, Nakashima Y, Matsushima T, Takahara K, Takasugi M, Kuroiwa A and Koide O (1986) Suppression of atherosclerosis in cholesterol-fed rabbits by diltiazem injection., Arteriosclerosis: An Official Journal of the American Heart Association, Inc., 6:2, (237-241), Online publication date: 1-Mar-1986. Betz E, Hämmerle H and Strohschneider T (1985) Inhibition of smooth muscle cell proliferation and endothelial permeability with flunarizine in vitro and in experimental atheromas, Research in Experimental Medicine, 10.1007/BF01851958, 185:4, (325-340), Online publication date: 1-Jul-1985. Tilton G, Buja L, Bilheimer D, Apprill P, Ashton J, McNatt J, Kita T and Willerson J (1985) Failure of a slow channel calcium antagonist, verapamil, to retard atherosclerosis in the watanabe heritable hyperlipidemic rabbit: An animal model of familial hypercholesterolemia, Journal of the American College of Cardiology, 10.1016/S0735-1097(85)80265-5, 6:1, (141-144), Online publication date: 1-Jul-1985. Parmley W, Blumlein S and Sievers R (1985) Modification of experimental atherosclerosis by calcium-channel blockers, The American Journal of Cardiology, 10.1016/0002-9149(85)90627-7, 55:3, (B165-B171), Online publication date: 1-Jan-1985. Yatsu F, Alam R and Alam S (1985) Enhancement of cholesteryl ester metabolism in cultured human monocyte-derived macrophages by verapamil, Biochimica et Biophysica Acta (BBA) - Molecular Cell Research, 10.1016/0167-4889(85)90155-7, 847:1, (77-81), Online publication date: 1-Oct-1985. Daoud A, Frank A, Jarmolych J, Franco W and Fritz K (1985) Ultrastructural and elemental analysis of calcification of advanced swine aortic atherosclerosis, Experimental and Molecular Pathology, 10.1016/0014-4800(85)90070-X, 43:3, (337-347), Online publication date: 1-Dec-1985. Blumlein S, Sievers R, Kidd P and Parmley W (1984) Mechanism of protection from atherosclerosis by verapamil in the cholesterol-fed rabbit, The American Journal of Cardiology, 10.1016/S0002-9149(84)80226-X, 54:7, (884-889), Online publication date: 1-Oct-1984. Ohata I, Sakamoto N, Nagano K and Maeno H (1984) Low density lipoprotein-lowering and high density lipoprotein-elevating effects of nicardipine in rats, Biochemical Pharmacology, 10.1016/0006-2952(84)90654-3, 33:14, (2199-2205), Online publication date: 1-Jul-1984. Kuo P, Wilson A, Goldstein R and Schaub R (1984) Suppression of experimental atherosclerosis in rabbits by interferon-inducing agents, Journal of the American College of Cardiology, 10.1016/S0735-1097(84)80438-6, 3:1, (129-134), Online publication date: 1-Jan-1984. DeFeudis F (1983) “Calcium-antagonists” and antherosclerosis — basic studies and therapeutic implications, Life Sciences, 10.1016/0024-3205(83)90199-6, 32:6, (557-563), Online publication date: 1-Feb-1983. Green D, Stone N and Krumlovsky F (1983) Putative atherogenic factors in patients with chronic renal failure, Progress in Cardiovascular Diseases, 10.1016/0033-0620(83)90027-0, 26:2, (133-144), Online publication date: 1-Sep-1983. Rouleau J, Parmley W, Stevens J, Wikman-Coffelt J, Sievers R, Mahley R and Havel R (1983) Verapamil suppresses atherosclerosis in cholesterol-fed rabbits, Journal of the American College of Cardiology, 10.1016/S0735-1097(83)80049-7, 1:6, (1453-1460), Online publication date: 1-Jun-1983. Leake D, Muir E and Bowyer D (1982) Modification of the rate of pinocytosis in arterial smooth muscle cells in culture, Experimental and Molecular Pathology, 10.1016/0014-4800(82)90098-3, 36:2, (262-275), Online publication date: 1-Apr-1982. Fleisch H (1981) Diphosphonates: History and mechanisms of action, Metabolic Bone Disease and Related Research, 10.1016/0221-8747(81)90044-8, 3:4-5, (279-287), Online publication date: 1-Jan-1981. Fleisch H (1981) Inhibitors of calcium phosphate precipitation and their role in biological mineralization, Journal of Crystal Growth, 10.1016/0022-0248(81)90059-2, 53:1, (120-134), Online publication date: 1-May-1981. Kramsch D, Aspen A and Rozler L (1981) Atherosclerosis: Prevention by Agents Not Affecting Abnormal Levels of Blood Lipids, Science, 10.1126/science.6792706, 213:4515, (1511-1512), Online publication date: 25-Sep-1981. Fleisch H (1980) Experimental basis for the clinical use of diphosphonates in paget's disease of bone, Arthritis & Rheumatism, 10.1002/art.1780231014, 23:10, (1162-1171), Online publication date: 1-Oct-1980. Horrobin D (1980) A new concept of lifestyle-related cardiovascular disease: The importance of interactions between cholesterol, essential fatty acids, prostaglandin E1 and thromboxane A2, Medical Hypotheses, 10.1016/0306-9877(80)90003-1, 6:8, (785-800), Online publication date: 1-Aug-1980. Yokoyama M and Henry P (1979) Sensitization of isolated canine coronary arteries to calcium ions after exposure to cholesterol., Circulation Research, 45:4, (479-486), Online publication date: 1-Oct-1979. April 1, 1978Vol 42, Issue 4 Advertisement Article InformationMetrics Copyright © 1978 by American Heart Associationhttps://doi.org/10.1161/01.RES.42.4.562 Originally publishedApril 1, 1978 PDF download Advertisement" @default.
• W2014839785 created "2016-06-24" @default.
• W2014839785 creator A5048494132 @default.
• W2014839785 creator A5064131956 @default.
• W2014839785 date "1978-04-01" @default.
• W2014839785 modified "2023-09-27" @default.
• W2014839785 title "The effect of agents interfering with soft tissue calcification and cell proliferation on calcific fibrous-fatty plaques in rabbits." @default.
• W2014839785 cites W1513741126 @default.
• W2014839785 cites W1970623516 @default.
• W2014839785 cites W1974798439 @default.
• W2014839785 cites W1975516631 @default.
• W2014839785 cites W1985342306 @default.
• W2014839785 cites W1995855048 @default.
• W2014839785 cites W1997293740 @default.
• W2014839785 cites W2021216796 @default.
• W2014839785 cites W2036892652 @default.
• W2014839785 cites W2040211672 @default.
• W2014839785 cites W2044292916 @default.
• W2014839785 cites W2045174923 @default.
• W2014839785 cites W2049545952 @default.
• W2014839785 cites W2050114343 @default.
• W2014839785 cites W2055571521 @default.
• W2014839785 cites W2064228165 @default.
• W2014839785 cites W2065727683 @default.
• W2014839785 cites W2070061946 @default.
• W2014839785 cites W2082146598 @default.
• W2014839785 cites W2082481602 @default.
• W2014839785 cites W2083491606 @default.
• W2014839785 cites W2102888883 @default.
• W2014839785 cites W2130768177 @default.
• W2014839785 cites W2136415420 @default.
• W2014839785 cites W2144181040 @default.
• W2014839785 cites W2314076285 @default.
• W2014839785 cites W2317158217 @default.
• W2014839785 cites W2324944988 @default.
• W2014839785 cites W2469025072 @default.
• W2014839785 cites W2478756475 @default.
• W2014839785 doi "https://doi.org/10.1161/01.res.42.4.562" @default.
• W2014839785 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/415824" @default.
• W2014839785 hasPublicationYear "1978" @default.
• W2014839785 type Work @default.
• W2014839785 sameAs 2014839785 @default.
• W2014839785 citedByCount "100" @default.
• W2014839785 countsByYear W20148397852012 @default.
• W2014839785 countsByYear W20148397852013 @default.
• W2014839785 countsByYear W20148397852014 @default.
• W2014839785 countsByYear W20148397852015 @default.
• W2014839785 countsByYear W20148397852018 @default.
• W2014839785 countsByYear W20148397852021 @default.
• W2014839785 countsByYear W20148397852023 @default.
• W2014839785 crossrefType "journal-article" @default.
• W2014839785 hasAuthorship W2014839785A5048494132 @default.
• W2014839785 hasAuthorship W2014839785A5064131956 @default.
• W2014839785 hasBestOaLocation W20148397851 @default.
• W2014839785 hasConcept C105702510 @default.
• W2014839785 hasConcept C136948725 @default.
• W2014839785 hasConcept C142724271 @default.
• W2014839785 hasConcept C1491633281 @default.
• W2014839785 hasConcept C171089720 @default.
• W2014839785 hasConcept C185592680 @default.
• W2014839785 hasConcept C2775981168 @default.
• W2014839785 hasConcept C2780309369 @default.
• W2014839785 hasConcept C55493867 @default.
• W2014839785 hasConcept C62112901 @default.
• W2014839785 hasConcept C71924100 @default.
• W2014839785 hasConcept C86803240 @default.
• W2014839785 hasConcept C95444343 @default.
• W2014839785 hasConceptScore W2014839785C105702510 @default.
• W2014839785 hasConceptScore W2014839785C136948725 @default.
• W2014839785 hasConceptScore W2014839785C142724271 @default.
• W2014839785 hasConceptScore W2014839785C1491633281 @default.
• W2014839785 hasConceptScore W2014839785C171089720 @default.
• W2014839785 hasConceptScore W2014839785C185592680 @default.
• W2014839785 hasConceptScore W2014839785C2775981168 @default.
• W2014839785 hasConceptScore W2014839785C2780309369 @default.
• W2014839785 hasConceptScore W2014839785C55493867 @default.
• W2014839785 hasConceptScore W2014839785C62112901 @default.
• W2014839785 hasConceptScore W2014839785C71924100 @default.
• W2014839785 hasConceptScore W2014839785C86803240 @default.
• W2014839785 hasConceptScore W2014839785C95444343 @default.
• W2014839785 hasIssue "4" @default.
• W2014839785 hasLocation W20148397851 @default.
• W2014839785 hasLocation W20148397852 @default.
• W2014839785 hasOpenAccess W2014839785 @default.
• W2014839785 hasPrimaryLocation W20148397851 @default.
• W2014839785 hasRelatedWork W1985201083 @default.
• W2014839785 hasRelatedWork W2065499985 @default.
• W2014839785 hasRelatedWork W2083693850 @default.
• W2014839785 hasRelatedWork W2142840491 @default.
• W2014839785 hasRelatedWork W2150263336 @default.
• W2014839785 hasRelatedWork W2320462481 @default.
• W2014839785 hasRelatedWork W2409550075 @default.
• W2014839785 hasRelatedWork W2411757410 @default.
• W2014839785 hasRelatedWork W2418343524 @default.
• W2014839785 hasRelatedWork W3029635938 @default.
• W2014839785 hasVolume "42" @default.
• W2014839785 isParatext "false" @default.
• W2014839785 isRetracted "false" @default.

• next